Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D275-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D275-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate |
1999-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2002-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2002509106-A |
titleOfInvention |
IL-8 receptor antagonist |
abstract |
(57) [Summary]nThe present invention relates to novel 1,8-naphthosultam-substituted compounds of formula (I) and compositions thereof useful in the treatment of conditions mediated by chemokines, interleukin-8 (IL-8). |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013534805-A |
priorityDate |
1998-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |